80
Apogem Capital closes PACD-CPE III 2026 at $35M for institutional investors
New fund · Private equity / buyout · Closed · NEW YORK, NY · Form D filed 2026-10-30 · sponsor: Apogem Capital · all Pacd Cpe vehicles · Follow Pacd Cpe →
Apogem Capital's PACD-CPE III 2026, a Delaware private equity fund, closed at $35M from 7 institutional investors with a $1M minimum. The fund filed under Regulation D exemption 3(c)(7) on October 30, 2026.
3(c)(7) — qualified purchasersFirst filing by this entityrepeat_fund_numeralPlacement agent engagedPrivate equity / buyout
How this compares
- $35M is larger than 74% of the 3,029 private equity / buyout fund launches with a stated size in the last two years; the median is $5M.
- Among 1,695 fund launches filed from NY in the same window it is larger than 74%; the NY median is $5M.
- Across 499 private equity / buyout sponsors with more than one launch on EDGAR, the median gap between consecutive funds is 5 months.
- No earlier fund launch by this sponsor appears on EDGAR.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
People on the filing
| N/A PACD MM, LLC | Director |
| John M. Grady | Executive Officer |
| Dorothy Kee Rabb | Executive Officer |
[email protected] · observed Work emails for the people on the filing, where the firm publishes or patterns them, labelled by confidence — subscribers
Signed by John Grady, CFO of Apogem Capital LLC the Investment Manager.
Placement agents / sales compensation: NY Life Distributors LLC
Why now — by persona
- Fund administrator:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Fund audit & tax:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans.